CLINICAL_TRIALS
trial_result
· 2016-10-20
Clinical Trial Update: A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2) [Phase 3]
Summary
Phase 3 study (UNCOVER-2) in moderate to severe psoriasis completed; results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Eli Lilly and Company | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2016-10-20